Benjamin J. Chen

1.9k total citations · 1 hit paper
19 papers, 1.3k citations indexed

About

Benjamin J. Chen is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Benjamin J. Chen has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Benjamin J. Chen's work include Cancer Immunotherapy and Biomarkers (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Immune Cell Function and Interaction (4 papers). Benjamin J. Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Immune Cell Function and Interaction (4 papers). Benjamin J. Chen collaborates with scholars based in United States, Netherlands and Russia. Benjamin J. Chen's co-authors include Christopher D.�M. Fletcher, Hongbo Yu, Scott J. Rodig, Mina L. Xu, Gordon J. Freeman, Margaret A. Shipp, Heather H. Sun, Bjoern Chapuy, Jing Ouyang and Margaretha G.M. Roemer and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Scientific Reports.

In The Last Decade

Benjamin J. Chen

19 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies

2013 657 citations Benjamin J. Chen, Bjoern Chapuy et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin J. Chen United States	12	820	548	495	194	190	19	1.3k
Sylvia Hoeller Switzerland	18	718 0.9×	595 1.1×	432 0.9×	255 1.3×	149 0.8×	35	1.3k
Adriana García‐Herrera Spain	19	554 0.7×	614 1.1×	295 0.6×	125 0.6×	80 0.4×	84	1.3k
W Vos Netherlands	23	753 0.9×	720 1.3×	416 0.8×	330 1.7×	86 0.5×	48	1.4k
José Cabeçadas Portugal	18	775 0.9×	772 1.4×	277 0.6×	272 1.4×	146 0.8×	65	1.4k
David Wu United States	21	1.1k 1.4×	556 1.0×	631 1.3×	516 2.7×	155 0.8×	65	2.4k
Florence Loong China	17	988 1.2×	1.1k 2.0×	523 1.1×	372 1.9×	88 0.5×	32	1.9k
Margaret Ashton‐Key United Kingdom	21	451 0.6×	473 0.9×	427 0.9×	289 1.5×	190 1.0×	44	1.3k
Kenneth MacLennan United Kingdom	20	712 0.9×	988 1.8×	381 0.8×	242 1.2×	241 1.3×	43	1.6k
David A. Wada United States	16	489 0.6×	665 1.2×	372 0.8×	83 0.4×	90 0.5×	52	1.2k
Zenggang Pan United States	17	483 0.6×	475 0.9×	177 0.4×	154 0.8×	72 0.4×	63	925

Countries citing papers authored by Benjamin J. Chen

Since Specialization

Citations

This map shows the geographic impact of Benjamin J. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Chen more than expected).

Fields of papers citing papers by Benjamin J. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin J. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Chen. The network helps show where Benjamin J. Chen may publish in the future.

Co-authorship network of co-authors of Benjamin J. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin J. Chen. A scholar is included among the top collaborators of Benjamin J. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin J. Chen. Benjamin J. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Krull, David, Anil K Kesarwani, Benjamin J. Chen, et al.. (2024). A best practices framework for spatial biology studies in drug discovery and development: enabling successful cohort studies using digital spatial profiling. Journal of Histotechnology. 48(1). 7–26. 3 indexed citations

Szabó, Péter M., Amir Vajdi, Namit Kumar, et al.. (2023). Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment. Scientific Reports. 13(1). 3051–3051. 36 indexed citations

Leontovich, Alexey A., Raymond M. Moore, Zachary C. Fogarty, et al.. (2022). Quantitative spatial evaluation of tumor-immune interactions in the immunotherapy setting of metastatic melanoma lymph nodes. Frontiers in Immunology. 13. 1024039–1024039. 5 indexed citations

Lyubetskaya, Anna, Brian Rabe, Andrew Fisher, et al.. (2022). Assessment of spatial transcriptomics for oncology discovery. Cell Reports Methods. 2(11). 100340–100340. 23 indexed citations

Makarenko, Vladislav, Alec Vaezi, Doreen B. Brettler, et al.. (2019). Laryngeal mucous membrane plasmacytosis with 15 year follow-up: Case report and literature review. Leukemia Research Reports. 13. 100190–100190. 3 indexed citations

Kriegsman, Barry, Pranitha Vangala, Benjamin J. Chen, et al.. (2019). Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression. The Journal of Immunology. 203(7). 1999–2010. 66 indexed citations

Chen, Benjamin J., Dashnamoorthy Ravi, Pallavi Galera, et al.. (2019). The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma. Oncotarget. 10(21). 2030–2040. 66 indexed citations

Zhu, Xiaoqin, Karen Dresser, & Benjamin J. Chen. (2019). Loss of 5‐hydroxymethylcytosine immunohistochemical expression is a useful diagnostic aid for distinguishing hepatocellular carcinoma in cytology fine needle aspiration specimens. Cytopathology. 30(5). 492–498. 4 indexed citations

Migdady, Yazan, Yiqin Xiong, Karen Dresser, et al.. (2018). Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience. Journal for ImmunoTherapy of Cancer. 6(1). 42–42. 16 indexed citations

10.

Wei, Xing, et al.. (2017). PD-L1 Immunohistochemistry Highlights Bone Marrow Involvement by Classic Hodgkin Lymphoma in Staging Biopsies: Implications for Diagnosis and Tumor Microenvironment Alterations. Applied immunohistochemistry & molecular morphology. 27(5). 356–363. 5 indexed citations

11.

Chen, Benjamin J., et al.. (2017). Indolent, waxing and waning cutaneous presentation of HTLV‐1‐associated adult T‐cell leukemia/lymphoma in an HIV‐1‐positive patient. Journal of Cutaneous Pathology. 45(2). 171–175. 5 indexed citations

12.

Kluk, Michael, Caleb Ho, Hongbo Yu, et al.. (2016). MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice. American Journal of Clinical Pathology. 145(2). 166–179. 22 indexed citations

13.

Wei, Xing, Karen Dresser, Rui Zhang, et al.. (2016). PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications. Oncotarget. 7(37). 59976–59986. 49 indexed citations

14.

Sakhdari, Ali, Jong Seo Lee, Keith Tomaszewicz, et al.. (2016). Immunohistochemical loss of 5‐hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways. Histopathology. 69(6). 1055–1065. 8 indexed citations

15.

Černý, Jan, Karen Dresser, Rajneesh Nath, et al.. (2014). MYC Protein Expression Is Detected in Plasma Cell Myeloma but Not in Monoclonal Gammopathy of Undetermined Significance (MGUS). The American Journal of Surgical Pathology. 38(6). 776–783. 21 indexed citations

16.

Černý, Jan, Muthalagu Ramanathan, Rajneesh Nath, et al.. (2014). Hemophagocytic lymphohistiocytosis secondary to T-cell/histiocyte-rich large B-cell lymphoma. Leukemia Research Reports. 3(2). 42–45. 14 indexed citations

17.

Chen, Benjamin J., Bjoern Chapuy, Jing Ouyang, et al.. (2013). PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies. Clinical Cancer Research. 19(13). 3462–3473. 657 indexed citations breakdown →

18.

Chen, Benjamin J., Adrián Mariño‐Enríquez, Christopher D.�M. Fletcher, & Jason L. Hornick. (2012). Loss of Retinoblastoma Protein Expression in Spindle Cell/Pleomorphic Lipomas and Cytogenetically Related Tumors. The American Journal of Surgical Pathology. 36(8). 1119–1128. 163 indexed citations

19.

Chen, Benjamin J., Makoto Takeda, & Robert A. Lamb. (2005). Influenza Virus Hemagglutinin (H3 Subtype) Requires Palmitoylation of Its Cytoplasmic Tail for Assembly: M1 Proteins of Two Subtypes Differ in Their Ability To Support Assembly. Journal of Virology. 79(21). 13673–13684. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact